-
Microb. Drug Resist. · Dec 2012
Multicenter StudyClinical experience of tigecycline treatment in infections caused by extensively drug-resistant Acinetobacter spp.
- Soo-Youn Moon, Kyong Ran Peck, Hyun-Ha Chang, Shin-Woo Kim, Sang Taek Heo, Jun Seong Son, Seong Yeol Ryu, Chisook Moon, Sook-In Jung, Sang Yop Shin, Jeong-a Lee, Mi-Kyong Joung, Doo-Ryeon Chung, Cheol-In Kang, and Jae-Hoon Song.
- Division of Infectious Diseases, Samsung Medical Center, Sungkyungkwan University School of Medicine, Seoul, Korea.
- Microb. Drug Resist. 2012 Dec 1;18(6):562-6.
BackgroundTigecycline has broad spectrum antimicrobial activity and is approved for complicated intra-abdominal infections, complicated skin and soft tissue infections, and community-acquired pneumonia. There are few data on clinical experience of tigecycline in hospital-acquired pneumonia (HAP) and Acinetobacter spp. infection.MethodsA retrospective study was performed at eight hospitals in Korea from May 2009 to January 2010. Adult patients treated with tigecycline regardless of their source of infection or pathogens were enrolled.ResultsTigecycline was administered in 108 patients. Pneumonia was the most common infection (43.5%), followed by skin and soft tissue infections (20.4%). Acinetobacter baumannii was isolated from 83 patients (76.9%) accounting for 50.3% of isolated pathogens, showing a resistance rate of 67.5% to carbapenems. Superinfection was identified in 32 patients (29.6%). Pseudomonas aeruginosa was most common microorganism causing superinfection (46.9%). Overall 30-day mortality rate was 52.9%. Thirty-day mortality rate of HAP and Acinetobacter spp. infection was 60.5% and 59.4%, respectively.ConclusionTigecycline can be considered as an alternative therapy in patients with HAP or infections caused by Acinetobacter spp., especially extensively drug-resistant A. baumannii.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*
,_underline_
or**bold**
. - Superscript can be denoted by
<sup>text</sup>
and subscript<sub>text</sub>
. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3.
, hyphens-
or asterisks*
. - Links can be included with:
[my link to pubmed](http://pubmed.com)
- Images can be included with:
![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
- For footnotes use
[^1](This is a footnote.)
inline. - Or use an inline reference
[^1]
to refer to a longer footnote elseweher in the document[^1]: This is a long footnote.
.